首页> 外国专利> Synergistic effects of amlopidina and atorvastatin or Atorvastatin metabolite as a basis for unaterapia combined.

Synergistic effects of amlopidina and atorvastatin or Atorvastatin metabolite as a basis for unaterapia combined.

机译:氨氯地平与阿托伐他汀或阿托伐他汀代谢物的协同作用作为联合治疗的基础。

摘要

This Invention is a Therapeutic Target for the treatment of coronary heart disease with the development of Drugs that can simultaneously Engage multiple Pathological processes subyacEntities that contribute to atherosclerosis, and thereby altering the trajectory of the disease.Therefore, by using this Invention, a mixture amlopidina and atorvastatinThe Therapy of Coronary Artery Disease may have more positive results, whether the use of an antihypertensive Agent and an HMG CoA reductase inhibitor were combined in a Delivery SystemUnique.
机译:本发明是用于治疗冠心病的治疗目标,其开发的药物可以同时参与多种导致动脉粥样硬化的病理过程亚活性,从而改变疾病的发展轨迹。无论将抗高血压药和HMG CoA还原酶抑制剂联合使用在Delivery SystemUnique中,冠状动脉疾病的治疗可能都有更积极的结果。

著录项

  • 公开/公告号GT200000121A

    专利类型

  • 公开/公告日2002-01-12

    原文格式PDF

  • 申请/专利权人

    申请/专利号GT20000000121

  • 发明设计人 R. PRESTON MASON.;

    申请日2000-07-21

  • 分类号C07D211/90;A61K31/365;A61K31/425;A61K31/44;

  • 国家 GT

  • 入库时间 2022-08-22 00:45:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号